|

The Global Fund to Fight AIDS, Tuberculosis and Malaria was launched in
2002 as result of global consensus that a new mechanism was
needed to finance a massive and rapid international effort to
combat AIDS, TB and Malaria, three diseases which stand as one
of the major components to the sustainable development of a
greater part of the world.
The
global fund was created around the concept of “performance-based
funding”. This meant that only those fund recipients who could
demonstrate measurable and effective results from the fund
received would be able to receive additional funding. In other
words initial funding is awarded solely on the basis of the
technical quality to the applications received but continued and
renewed funding depends upon proven results and targets
achieved. The GFATM’s performance-based funding system provided
a platform for the grant recipients to demonstrate and prove
their achievements. The GFATM has committed itself to fund 10
billion to support 136 countries through its first seven rounds
of grant-making.
The GFATM
is the largest contributor to NTP. Its contribution is
increasing over the years. Under GFATM (Round 3) funding, the
NGOs were the major sub-recipients and received 60% of the
funding under Principal Recipient BRAC, whereas under GFATM
Round 5 funding, approximately 60% of the grant is being
channeled through the Government Principal Recipient (Economics
Relations Division under Ministry of Finance).
-
The
World Health Organization (WHO)
-
The
Canadian International Development Agency (CIDA)
-
The
Royal Netherlands Tuberculosis Association
(KNCV Tuberculosis Foundation), The Research Institute
of Tuberculosis (RIT), Japan
-
The
International Union Against Tuberculosis and Lung
Disease (The Union); Management Sciences for Health (MSH)
-
The University Research Corporation (URC)
-
The United States Agency for
International Development (USAID), USA and some
international academic institutes have also provided
financial and technical support.
.
|
|